Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-24

Clinical Trial Update: Natural History Study of Patients With Neurofibromatosis Type 2

View source ↗

Summary

Natural history study of patients with Neurofibromatosis Type 2, currently recruiting to observe disease progression and clinical features over time.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Neurofibromatosis | Status: RECRUITING